Showing results (221-230 of 241) with videos related to

Sort By:
Pageof 25
Lung Cancer (Amsterdam, Netherlands)|December 15, 2020
Nivolumab versus docetaxel in a predominantly Chinese patient population with previously treated advanced non-small cell lung cancer: 2-year follow-up from a randomized, open-label, phase 3 study (CheckMate 078)Shun Lu, Jie Wang, Ying Cheng, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 28, 2021
Sintilimab Plus Platinum and Gemcitabine as First-Line Treatment for Advanced or Metastatic Squamous NSCLC: Results From a Randomized, Double-Blind, Phase 3 Trial (ORIENT-12)Caicun Zhou, Lin Wu, Yun Fan, et al.
Allergy, Asthma & Immunology Research|March 7, 2020
Hospitalization Due to Asthma Exacerbation: A China Asthma Research Network (CARN) Retrospective Study in 29 Provinces Across Mainland ChinaJiangtao Lin, Bin Xing, Huaping Tang, et al.
The Lancet. Oncology|May 16, 2022
Adebrelimab or placebo plus carboplatin and etoposide as first-line treatment for extensive-stage small-cell lung cancer (CAPSTONE-1): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trialJie Wang, Caicun Zhou, Wenxiu Yao, et al.
BMC Pulmonary Medicine|July 1, 2022
Associations between comorbidities and annual incidence plus frequency of asthma exacerbation hospitalisation during the past year: data from CARN studyWenqiao Wang, Jiangtao Lin, Xin Zhou, et al.
Allergy, Asthma & Immunology Research|January 4, 2022
Asthma Management Using the Mobile Asthma Evaluation and Management System in ChinaJiangtao Lin, Wenya Wang, Huaping Tang, et al.
Lung Cancer (Amsterdam, Netherlands)|January 30, 2022
Three-year follow-up and patient-reported outcomes from CheckMate 078: Nivolumab versus docetaxel in a predominantly Chinese patient population with previously treated advanced non-small cell lung cancerJianhua Chang, Yi-Long Wu, Shun Lu, et al.
Journal of Cancer|September 11, 2020
The development of bronchoscopy in China: a national cross-sectional studyDongchen Shi, Fuqi Li, Kaicheng Wang, et al.
Translational Lung Cancer Research|May 19, 2020
Circulating tumor DNA clearance predicts prognosis across treatment regimen in a large real-world longitudinally monitored advanced non-small cell lung cancer cohortYong Song, Chengping Hu, Zhanhong Xie, et al.
Plos One|June 22, 2012
Etiologic diagnosis of lower respiratory tract bacterial infections using sputum samples and quantitative loop-mediated isothermal amplificationYu Kang, Rui Deng, Can Wang, et al.
Pageof 25